We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $148B Turnover 12.67%
1-Year Est. Return 31.56%
 

Neuberger Berman is an employee-owned investment manager that runs stock, bond, private equity and hedge fund portfolios for institutions, advisers and high net worth individuals. Art collector Roy Neuberger and banker Robert Berman co-founded the firm in 1939. Lehman Brothers bought it in 2003, and after Lehman collapsed in 2008 the firm's own managers won a bankruptcy auction for it, spinning it off in 2009 and returning it to full employee ownership by the end of 2014. Since going independent it has moved beyond its traditional focus on stocks into emerging markets debt, high-yield bonds and private equity, and in 2024 it led a private equity group that agreed to buy the school operator Nord Anglia Education. Art has been part of the firm's workplace culture since Roy Neuberger co-founded it, and it bought back many pieces of its collection at auction in 2010 after Lehman had absorbed them.

This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+31.56%
3 Year Est. Return
+123.69%
5 Year Est. Return
+143.81%
10 Year Est. Return
+543.91%
AUM
$72.6B
AUM Growth
-$158M
Cap. Flow
-$2.42B
Cap. Flow %
-3.33%
Top 10 Hldgs %
9.36%
Holding
1,641
New
164
Increased
556
Reduced
733
Closed
111
Avg Time Held Equity + Options
2.1 years
Top 10 Avg Time Held Equity + Options
1.2 years
Top 20 Avg Time Held Equity + Options
1.5 years
Avg Time Held Equity only
2.1 years
Top 10 Avg Time Held Equity only
1.2 years
Top 20 Avg Time Held Equity only
1.5 years

Sector Composition

Rank Sector Weight
1 Financials 14.88%
2 Healthcare 14.05%
3 Technology 14.02%
4 Industrials 12.94%
5 Energy 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JPM icon
1
JPMorgan Chase
JPM
$919B
$1.08B 1.49%
17,447,748
-1,311,272
-7% -$81.9M
2013 Q2
12 quarters
PFE icon
2
Pfizer
PFE
$165B
$842M 1.16%
25,190,253
-1,743,253
-6% -$55.6M
2013 Q2
12 quarters
MSFT icon
3
Microsoft
MSFT
$3.89T
$724M 1%
14,157,487
-111,716
-0.8% -$5.81M
2013 Q2
12 quarters
SLB icon
4
SLB Ltd
SLB
$76.3B
$633M 0.87%
8,009,259
+352,585
+5% +$27M
2013 Q2
12 quarters
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.26T
$617M 0.85%
4,264,167
+307,898
+8% +$44M
2013 Q2
12 quarters
AAPL icon
6
Apple
AAPL
$5.18T
$617M 0.85%
25,807,840
-824,016
-3% -$20.5M
2013 Q2
12 quarters
JNJ icon
7
Johnson & Johnson
JNJ
$688B
$599M 0.82%
4,934,135
-563,020
-10% -$64M
2013 Q2
12 quarters
AON icon
8
Aon
AON
$71.8B
$566M 0.78%
5,183,131
-564,622
-10% -$59.7M
2013 Q2
12 quarters
ORCL icon
9
Oracle
ORCL
$391B
$556M 0.77%
13,582,769
-232,774
-2% -$9.3M
2013 Q2
12 quarters
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.6T
$552M 0.76%
15,955,400
+3,961,940
+33% +$142M
2013 Q2
12 quarters
EPD icon
11
Enterprise Products Partners
EPD
$82.6B
$550M 0.76%
18,804,774
-638,291
-3% -$17.1M
2013 Q2
12 quarters
EOG icon
12
EOG Resources
EOG
$82.1B
$536M 0.74%
6,426,655
+617,525
+11% +$49.5M
2013 Q2
12 quarters
PXD icon
13
DELISTED
Pioneer Natural Resource Co.
PXD
$502M 0.69%
3,318,592
-145,301
-4% -$22.8M
2013 Q2
12 quarters
AGN
14
DELISTED
Allergan plc
AGN
$467M 0.64%
2,020,395
+810,232
+67% +$187M
2013 Q2
12 quarters
ET icon
15
Energy Transfer Partners
ET
$66.8B
$463M 0.64%
32,194,229
-11,119,104
-26% -$133M
2013 Q2
12 quarters
CVS icon
16
CVS Health
CVS
$114B
$459M 0.63%
4,792,172
-160,039
-3% -$15.9M
2013 Q2
12 quarters
OKE icon
17
Oneok
OKE
$56.6B
$458M 0.63%
9,656,760
-1,429,104
-13% -$56.7M
2013 Q2
12 quarters
PG icon
18
Procter & Gamble
PG
$394B
$451M 0.62%
5,322,932
+1,503,614
+39% +$123M
2013 Q2
12 quarters
CHD icon
19
Church & Dwight Co
CHD
$26.7B
$432M 0.6%
8,401,472
-337,118
-4% -$16.3M
2013 Q2
12 quarters
GS icon
20
Goldman Sachs
GS
$264B
$420M 0.58%
2,828,643
-272,801
-9% -$42.6M
2013 Q2
12 quarters
ICE icon
21
Intercontinental Exchange
ICE
$100B
$419M 0.58%
8,188,470
+842,845
+11% +$42.5M
2013 Q2
12 quarters
XRAY icon
22
Dentsply Sirona
XRAY
$1.83B
$413M 0.57%
6,653,874
+390,062
+6% +$24M
2014 Q2
8 quarters
CMCSA icon
23
Comcast
CMCSA
$89.3B
$408M 0.56%
12,528,960
-982,218
-7% -$30.5M
2013 Q2
12 quarters
BMY icon
24
Bristol-Myers Squibb
BMY
$130B
$407M 0.56%
5,530,236
-580,494
-9% -$41M
2013 Q2
12 quarters
PGR icon
25
Progressive
PGR
$137B
$406M 0.56%
12,107,909
-932,634
-7% -$30.9M
2013 Q2
12 quarters

Similar funds

Neuberger Berman Group's Q2 2016 Portfolio in Review

As of Q2 2016, Neuberger Berman Group held 1,641 positions worth $72.6B, down 0.22% from $72.7B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Neuberger Berman Group withdrew a net $2.42B in Q2 2016, closing 111 positions and reducing 733 holdings. Its most notable exit was SANDISK CORP, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Neuberger Berman Group opened a new position in ANTERO MIDSTREAM PARTNERS LP worth $94.9M.

  • Neuberger Berman Group's largest Q2 2016 buy was ANTERO MIDSTREAM PARTNERS LP: 3,405,308 shares worth $94.9M.
  • Neuberger Berman Group added most to Allergan plc in Q2 2016, an estimated $187M increase.
  • Neuberger Berman Group's biggest Q2 2016 reduction was Intuit, cutting an estimated $210M.
  • Neuberger Berman Group fully exited SANDISK CORP in Q2 2016, selling an estimated $115M.
  • Neuberger Berman Group's ten largest holdings make up 9.4% of its $72.6B portfolio in Q2 2016.
  • Neuberger Berman Group opened 164 new positions and closed 111 in Q2 2016.
  • Neuberger Berman Group's portfolio value fell 0.22% quarter-over-quarter to $72.6B.

Based on Neuberger Berman Group's 13F filing for Q2 2016, filed 5 Aug 2016.